Finance

Lists
CLB:NYSE
Core Laboratories Inc
$11.16
+1.92%
(+0.21) 1D
Aug 6, 10:21:27 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLB...
Open
$11.07
High
$11.16
Low
$10.98
Mkt. cap
509.32M
Avg. vol.
0.00
Volume
14.23K
Dividend
0.36%
Quarterly dividend
$0.01
Ex-dividend date
Aug 10, 2026
P/E ratio
21.47
52-wk high
$20.36
52-wk low
$9.72
EPS
$0.52
Beta
1.03
Shares outstanding
45.88M
No. of employees
3K
Open
$11.07
High
$11.16
Low
$10.98
Mkt. cap
509.32M
Avg. vol.
0.00
Volume
14.23K
Dividend
0.36%
Quarterly dividend
$0.01
Ex-dividend date
Aug 10, 2026
P/E ratio
21.47
52-wk high
$20.36
52-wk low
$9.72
EPS
$0.52
Beta
1.03
Shares outstanding
45.88M
No. of employees
3K
News stories
From sources across the web
Profile
Core Laboratories Inc is an American service provider of core and fluid analysis in the petroleum industry. Established in 1936, Core Lab is a global provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. Wikipedia
About Core Laboratories Inc
CEOLawrence Bruno
Employees3.3K
Founded1936
HeadquartersAmsterdam, North Holland, Netherlands
SectorEnergy
Analyst ratings
Based on 1 analyst giving stock ratings to CLB in the past 3 months
Sell
Buy
0
Hold
0
Sell
1
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CLB in the last 3 months
Highest
Current $11.16
$11.00 (-1.43%)
Average
$11.00 (-1.43%)
Lowest
$11.00 (-1.43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Saurabh Pant
Bank of America Securities
Sell
Reiterated
$11.00
-1.4%
07/15/2026
Unknown Analyst
Bank of America Securities
Sell
Maintained
$11.00
-1.4%
07/15/2026
Scott Gruber
Citi
Hold
Maintained
$12.00
+7.5%
10/10/2025
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.11 / $0.09
+22.22%beat
Revenue / Est. (USD)
124.61M / 125.10M
-0.39%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
134.52M
138.26M
121.80M
124.61M
Cost of goods sold
104.90M
109.52M
102.07M
101.37M
Cost of revenue
104.90M
109.52M
102.07M
101.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.38M
10.32M
14.37M
10.61M
Operating expense
13.60M
13.63M
17.75M
14.06M
Total operating expenses
118.50M
123.14M
119.82M
115.44M
Operating income
16.02M
15.11M
1.97M
9.17M
Other non operating income
-
-
-
-
EBT including unusual items
18.28M
13.22M
-1.00M
6.30M
EBT excluding unusual items
12.83M
12.34M
-1.38M
5.92M
Income tax expense
3.75M
8.09M
-251.00K
507.00K
Effective tax rate
20.54%
61.21%
25.00%
8.04%
Other operating expenses
-375.00K
-358.00K
-380.00K
-368.00K
Net income
14.24M
4.95M
-789.00K
5.96M
Net profit margin
10.58%
3.58%
-0.65%
4.78%
Earnings per share
0.22
0.21
0.06
0.11
Interest and investment income
-
-
-
-
Interest expense
-2.65M
-2.61M
-2.89M
-2.85M
Net interest expenses
-2.65M
-2.61M
-2.89M
-2.85M
Depreciation and amortization charges
3.53M
3.61M
3.56M
3.68M
EBITDA
19.62M
18.78M
5.74M
13.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps